Analysis

What to expect when Philip Morris (PM) reports Q1 2024 earnings

Shares of Philip Morris International Inc. (NYSE: PM) stayed red on Monday. The stock has dropped over 6% year-to-date. The tobacco giant

JPM, WFC, C: Here’s a look at how these major banks performed in Q1 2024

Banking giants JPMorgan Chase & Co. (NYSE: JPM), Wells Fargo & Company (NYSE: WFC), and Citigroup Inc. (NYSE: C) reported their earnings

Earnings Preview: UnitedHealth (UNH) looks poised to deliver another strong quarter

After delivering a solid performance last year, UnitedHealth Group (NYSE: UNH) will be reporting first-quarter financial data next week. The healthcare conglomerate’s

Interviews

AlphaStreet's dedicated Earnings Call section is your one-source destination for all publicly listed earnings conference calls. Listen to CEOs/CFOs discuss their company's earnings reports while Wall Street Analysts ask (or grill) with their hard hitting questions.

Most Read

Charles Schwab (SCHW) Q1 2024 Earnings: Key financials and quarterly highlights

The Charles Schwab Corporation (NYSE: SCHW) reported first quarter 2024 earnings results today. Net revenues decreased 7% year-over-year to $4.74 billion. Net income available to common shareholders was $1.25 billion,

April 15, 2024

GS Earnings: All you need to know about Goldman Sachs’ Q1 2024 earnings results

The Goldman Sachs Group, Inc. (NYSE: GS) reported its first quarter 2024 earnings results today. Net revenues were $14.21 billion, up 16% from the same period last year. Net earnings

April 15, 2024

Centuri Holdings takes the IPO route to expand. Here’s all you need to know

Utility infrastructure service provider Centuri Holdings, Inc. has initiated an initial public offering as it seeks to spin off from parent company Southwest Gas Holdings and become an independent entity.

April 12, 2024

Research Summary

Ocean Biomedical, Inc. (NASDAQ: OCEA) Research Summary

Ocean Biomedical, Inc. (NASDAQ: OCEA) is a biotechnology company that works with leading researchers

Trxade Health Inc. (NASDAQ: MEDS) Q4 2023 Research Summary

Trxade Health, Inc. (NASDAQ: MEDS) operates as an integrated drug procurement and delivery platform,

Viewing Highlight
Loading...
Highlight
Close
Top